The company said the recall follows the presence of visible particles found in some retained samples of the lot. No other lots or sizes of phenylephrine HCI injection are being recalled.
Phenylephrine HCI injection is intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anesthesia and for the treatment of vascular failure in shock, shock-like states and drug-induced states.
Related Articles on Anesthesia:
Study: Older Anesthesiologists Experience More, Greater Severity of Litigation
Anesthesiologist Sues 1-800-GET-THIN President Over Alleged Identity Theft
Teva Settles Lawsuit Over Hep C Outbreak
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
